XML 19 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue and Contract Acquisition Costs
 9 Months Ended
Sep. 30, 2022
Revenue from Contract with Customer [Abstract]  
Revenue and Contract Acquisition Costs Revenue and Contract Acquisition Costs
The following table summarizes the Company’s disaggregated revenue:
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2022202120222021
U.S. Omnipod$238.1 $167.2 $608.6 $461.0 
International Omnipod88.0 93.1 272.8 274.6 
Total Omnipod326.1 260.3 881.4 735.6 
Drug Delivery14.7 15.3 54.2 55.5 
Total revenue$340.8 $275.6 $935.6 $791.1 
The percentages of total revenue for customers that represent 10% or more of total revenue were as follows:
Three Months Ended September 30,Nine Months Ended September 30,

2022202120222021
Distributor A17%*18%*
Distributor B18%14%16%12%
Distributor C***13%
Distributor D17%*15%*
Distributor E10%***
* Represents less than 10% of revenue for the period.
Deferred revenue related to unsatisfied performance obligations was included in the following consolidated balance sheet accounts in the amounts shown:
(in millions)
September 30, 2022December 31, 2021
Accrued expenses and other current liabilities$9.0 $3.5 
Other liabilities1.5 1.5 
Total deferred revenue$10.5 $5.0 
Revenue recognized from amounts included in deferred revenue at the beginning of each respective period was as follows:
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2022202120222021
Deferred revenue recognized$0.3 0.1 $1.8 4.0 
Contract acquisition costs, representing capitalized commission costs related to new customers, net of amortization, were included in the following consolidated balance sheet captions in the amounts shown:
(in millions)September 30, 2022December 31, 2021
Prepaid expenses and other current assets$14.2 $13.3 
Other assets28.2 26.1 
Total capitalized contract acquisition costs, net$42.4 $39.4 
The Company recognized $3.7 million and $3.2 million of amortization of capitalized contract acquisition costs during the three months ended September 30, 2022 and 2021, respectively. The Company recognized $10.7 million and $9.1 million of amortization of capitalized contract acquisition costs during the nine months ended September 30, 2022 and 2021, respectively.